接受低剂量阿哌沙班超说明书用药治疗患者的血浆阿哌沙班水平 - Suppr

Suppr

超能文献

Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose.

作者信息

Bhagirath Vinai C, Chan Noel, Hirsh Jack, Ginsberg Jeffrey, de Vries Tim A C, Eikelboom John

出版信息

J Am Coll Cardiol. 2020 Dec 15;76(24):2906-2907. doi: 10.1016/j.jacc.2020.09.615.

DOI:10.1016/j.jacc.2020.09.615

PMID:33303080

Abstract

摘要

相似文献

Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose.接受低剂量阿哌沙班超说明书用药治疗患者的血浆阿哌沙班水平

J Am Coll Cardiol. 2020 Dec 15;76(24):2906-2907. doi: 10.1016/j.jacc.2020.09.615.

Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial.ARISTOTLE 试验中依度沙班剂量调整的临床和药理学效应。

J Am Coll Cardiol. 2020 Mar 17;75(10):1145-1155. doi: 10.1016/j.jacc.2019.12.060.

Apixaban: a new direct oral anticoagulant for stroke prevention in atrial fibrillation.阿哌沙班：预防心房颤动卒中的新型口服直接抗凝剂。

Eur Heart J. 2014 Jul 21;35(28):1828-9.

Rivaroxaban and Apixaban Anti-Xa Measurements: Impact of Plasma Storage for 7 Days at Room Temperature.利伐沙班和阿哌沙班的抗Xa测定：室温下血浆储存7天的影响。

Thromb Haemost. 2018 Aug;118(8):1488-1490. doi: 10.1055/s-0038-1661391. Epub 2018 Jun 30.

Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care.药物相互作用和遗传药理学因素导致常规治疗中房颤患者阿哌沙班浓度的变化。

J Thromb Thrombolysis. 2020 Feb;49(2):294-303. doi: 10.1007/s11239-019-01962-2.

Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing.标准剂量适用的房颤患者中，非维生素K拮抗剂口服抗凝药超说明书低剂量用药的模式及影响

Am J Cardiol. 2020 May 1;125(9):1332-1338. doi: 10.1016/j.amjcard.2020.01.044. Epub 2020 Feb 8.

Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.真实世界中抗 Xa 口服抗凝药血浆浓度测定：使用低分子肝素校准品对急诊中利伐沙班和阿哌沙班进行定量分析。

Ann Pharmacother. 2019 Apr;53(4):341-347. doi: 10.1177/1060028018811657. Epub 2018 Oct 31.

Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.法国非瓣膜性心房颤动患者中阿哌沙班预防卒中和全身性栓塞：PAROS 横断面研究常规临床实践。

Arch Cardiovasc Dis. 2019 Jun-Jul;112(6-7):400-409. doi: 10.1016/j.acvd.2019.02.003. Epub 2019 Apr 20.

Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation.应用抗因子 Xa 分析法检测急性缺血性脑卒中合并非瓣膜性心房颤动患者的阿哌沙班。

J Thromb Thrombolysis. 2018 Feb;45(2):250-256. doi: 10.1007/s11239-017-1590-1.

Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system.比较达比加群、利伐沙班和阿哌沙班在非瓣膜性心房颤动患者中的安全性和有效性：来自大型医疗保健系统的回顾性研究。

Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):80-90. doi: 10.1093/ehjcvp/pvy044.

引用本文的文献

Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.直接口服抗凝剂治疗心房颤动患者的药物浓度通常治疗范围：一项系统评价和荟萃分析

Thromb Haemost. 2025 Jun;125(6):563-573. doi: 10.1055/a-2446-1348. Epub 2024 Nov 21.

Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Decade of Experience.直接口服抗凝剂在老年和虚弱的房颤患者中的应用：十年经验。

Drugs Aging. 2024 Sep;41(9):725-740. doi: 10.1007/s40266-024-01138-5. Epub 2024 Aug 14.

Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动老年患者常规临床护理中的阿哌沙班浓度

JACC Adv. 2022 Jun;1(2). doi: 10.1016/j.jacadv.2022.100039. Epub 2022 May 23.

Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review.老年心房颤动患者直接口服抗凝剂的药代动力学和药效学洞察：一项结构化叙述性综述

Clin Pharmacokinet. 2023 Mar;62(3):351-373. doi: 10.1007/s40262-023-01222-w. Epub 2023 Mar 2.

Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory Study.衰弱作为老年患者直接口服抗凝剂血浆浓度标志物的研究：一项探索性研究的结果。

Drugs Aging. 2023 Feb;40(2):153-164. doi: 10.1007/s40266-022-00999-y. Epub 2023 Jan 13.

Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study.阿哌沙班水平的单次测量能否识别有暴露过量风险的患者？一项前瞻性队列研究。

TH Open. 2022 Jan 24;6(1):e10-e17. doi: 10.1055/s-0041-1740492. eCollection 2022 Jan.

Critical Analysis of Apixaban Dose Adjustment Criteria.阿哌沙班剂量调整标准的批判性分析。

Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211021158. doi: 10.1177/10760296211021158.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验